SEC Form 4 · accession 0001140361-15-028720
VASCULAR SOLUTIONS INC · VASC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy Slayton
Officer — Principal Accounting Officer
Period of report
Jul 23, 2015
Accepted (ET)
Jul 27, 2015 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001030206
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jul 23, 2015 | S | 1,587 | $38.61 | D | 9,046 | D | |
| Common StockF1 | holding | — | — | — | 10,633 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Increase from last filing represents 431 shares acquired under the Vascular Solutions Stock Purchase Plan for the period ending April 30, 2015 at $18.05 per share.
- F2The price in column 4 is a weighted average price. The prices actually received for the stock ranged from $38.47 to $39.00 per share. Mr. Slayton has provided to the Company and, upon request, will provide any security holder of the Company, or the SEC staff, information regarding the number of shares sold at each price within that range.